Related Experiment Video
Updated: Jun 3, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
N-Acetyltransferase polymorphism and human cancer risk
X Yang1, T Takeshita, K Morimoto
1Department of Social and Environmental Medicine, Osaka University Graduate School of Medicine Fl, Osaka.
Environmental Health and Preventive Medicine
|March 25, 2011
Summary
N-acetyltransferase (NAT) enzyme variants show a weak link to cancer risk. Environmental factors like smoking and diet, alongside gene interactions, may play a more significant role in cancer susceptibility.
Area of Science:
- Biochemistry
- Genetics
- Cancer Research
Background:
- N-acetyltransferase (NAT) enzymes are crucial for metabolizing carcinogens like arylamines.
- Previous research explored NAT variants' role in cancer susceptibility.
- Understanding NAT1 and NAT2 isozymes' impact on cancer risk is important.
Purpose of the Study:
- To investigate the association between NAT1 and NAT2 acetylator types and cancer risk.
- To explore the influence of environmental factors and gene interactions on cancer development.
Main Methods:
- Examined the relationship between NAT1 and NAT2 acetylator phenotypes and cancer risk.
- Considered individual genetic profiles and exposure to environmental precarcinogens.
Main Results:
- No strong independent association was found between NAT1 or NAT2 acetylation and overall cancer risk.
- Smoking and red meat intake showed associations with NAT1 and NAT2 genotypes in carcinogenesis.
- Potential gene-gene interactions or linkage between NAT1 and NAT2 were suggested.
Conclusions:
- The direct link between NAT1/NAT2 acetylation type and cancer risk appears weak.
- Environmental exposures and genetic interactions are critical factors in cancer development.
- Further research into gene-gene interactions and environmental influences is warranted.
Related Concept Videos
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:24Phase II Reactions: Acetylation Reactions
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...